Table 2

Cardiac MRI data comparison between patients and control subjects

Subjects with type 2 diabetesControl subjectsP value
LV volumes and function
 Indexed end-diastolic volume (mL/m2)73.0 ± 11.691.7 ± 16.3<0.001
 Indexed end-systolic volume (mL/m2)28.6 ± 7.638.1 ± 9.4<0.001
 Stroke volume (mL)95.8 ± 20.795.5 ± 22.90.965
 Ejection fraction (%)61.1 ± 6.558.8 ± 5.50.156
 LV mass (g)99.5 ± 24.889.1 ± 36.90.017
 LV mass index (g/m2)40.9 ± 8.235.8 ± 12.00.028
 LV mass/volume (g/mL)0.64 ± 0.130.54 ± 0.120.003
Aortic imaging
 Ascending AD (mmHg−1 × 10−3)4.85 ± 2.216.12 ± 1.780.010
 Descending AD (mmHg−1 × 10−3)3.87 ± 1.554.83 ± 1.460.013
 Mean AD (mmHg−1 × 10−3)4.36 ± 1.815.47 ± 1.560.012
Tissue characterization
 LGE present, n (%)7 (9.3)1 (5)0.549
  • Data are mean ± SD unless stated otherwise. Statistically significant data (P < 0.05) appear in boldface type.